AVTX Competitors & Alternatives
Compare Avalo Therapeutics Inc with similar stocks in the same industry
Biotechnology
AVTX
Main Stock$6.93
Tradestie Score
42
Market Cap
$170.45M
Revenue Growth
-0.7%
Analyst Upside
+494.3%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$6.78
|
$422.50M | - | 37 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$52.48
|
$410.79M | - | 46 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.80
|
$407.71M | - | 53 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.24
|
$386.68M | - | 53 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.30
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.16
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.37
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$38.73
|
$353.70M | 394.2 | 48 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.41
|
$350.98M | - | 68 | Compare |
More AVTX Analysis
Data updated: Oct 26, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry